Sandoz Gets Canada Approval for Generic Version of Ozempic

The approval for its generic version of diabetes drug Ozempic advances its efforts to build a portfolio of GLP-1 medicines.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。